Results 191 to 200 of about 29,884 (295)

Comparative Clinical Trajectories Across Cannabis‐Related and Nonsubstance‐Related Psychoses

Acta Psychiatrica Scandinavica, Volume 154, Issue 2, Page 142-152, August 2026.
ABSTRACT Background Research indicates that first‐episode psychosis (FEP) with cannabis use disorder (CUD) carries a substantial disease burden, but more granular clinical trajectories of cannabis‐related psychoses remain unclear. This study examines the clinical trajectories of first clinically diagnosed FEP&CUD and cannabis‐induced psychosis (CIP) in
Antti Mustonen, Solja Niemelä, Alexander Denissoff, Antti Tanskanen, Ellenor Mittendorfer‐Rutz, Markku Lähteenvuo, Jari Tiihonen, Heidi Taipale   +7 more
wiley   +1 more source

Leveraging Machine Learning to Predict Food Waste Quantity: Focusing on Military Dining Facilities as Large‐Scale Food Service Operations

Journal of Forecasting, Volume 45, Issue 4, Page 2001-2016, July 2026.
ABSTRACT Food waste reveals inefficiencies in resource use and contributes significantly to environmental pollution. In the United States, food waste accounts for the majority of total waste, with more than 50 million tons generated annually. In military units that operate large‐scale institutional food‐service facilities and generate significant food ...
YongSun Kim, Hyun Shik Yoon
wiley   +1 more source

Mechanotransduction in the Brain: Soliton Theory, Piezo Receptors and MR Elastography in Headache Pathophysiology. [PDF]

Brain Behav
Crespi J, Nyman AKG, Tronvik E, Pellesi L, Petrušić I, Schröder TN.   +5 more
europepmc   +1 more source

Efficacy of high‐frequency low‐dose rituximab and acalabrutinib in chronic lymphocytic leukemia

HemaSphere, Volume 10, Issue 7, July 2026.
Abstract Anti‐CD20 monoclonal antibodies (mAbs) are effective but not curative treatment for chronic lymphocytic leukemia (CLL). To study rituximab efficacy, we examined serial blood samples from CLL patients receiving initial monotherapy with high‐frequency low‐dose (HFLD) rituximab for 1 week followed by the addition of acalabrutinib.
Charles C. Chu, Clare B. Heffernan, Nydia C. Jaimes‐Delgadillo, Christine A. Herne, Jennifer E. Bruno, Andrea M. Baran, John M. Ashton, Timothy R. Mosmann, Paul M. Barr, Ronald P. Taylor, Michael R. Elliott, Clive S. Zent   +11 more
wiley   +1 more source

A simple MR enterography assessment of Crohn disease activity based on the most affected bowel segment: A retrospective cohort study. [PDF]

Medicine (Baltimore)
Seo N, Lim JS, Kim SS, Bae H, Kang EA, Cheon JH.   +5 more
europepmc   +1 more source

Upper and small bowel Crohn's disease in Brazilian children: Phenotypic characteristic and surgical risk

Journal of Pediatric Gastroenterology and Nutrition, Volume 83, Issue 1, Page 87-95, July 2026.
Abstract Objectives Upper and small bowel Crohn's disease (U‐SBCD) represents a clinically aggressive phenotype with high complication rates yet remains diagnostically challenging. In low‐ and middle‐income countries (LMICs), limited inflammatory bowel disease (IBD) awareness contributes to diagnostic delays, but their impact on U‐SBCD outcomes remains
Jane Oba, Carlos Walter Sobrado, Elizete Aparecida Lomazi, Mariana Deboni, Michela Cynthia da Rocha Marmo, Vanessa Adriana Scheeffer, Silvio da Rocha Carvalho, Adérson Omar Mourão Cintra Damião, Matheus Freitas Cardoso de Azevedo, Carlos Frederico Sparapan Marques, Eytan Wine, Artur Figueiredo Delgado, Clovis Artur Almeida da Silva Full   +12 more
wiley   +1 more source

Magnetic Resonance Enterography Predicts Long-Term Outcomes in Crohn's Disease: A Systematic Review and Meta-Analysis. [PDF]

JGH Open
Wu S, Yang J, Jizhi S, Liu A, Chen X, Chen Z, Zheng S.   +6 more
europepmc   +1 more source

MRE data analysis

NCTAM papers, National Congress of Theoretical and Applied Mechanics, Japan, 2012
openaire   +1 more source

Psychological distress links to magnetic resonance enterography abnormalities in Crohn's disease. [PDF]

Insights Imaging
Zhang R, Ke Y, Cai H, Wang Y, Huang L, Shen X, Zheng Q, Wu L, Zhao Q, Zheng W, Li D, Mao R, Li Z, Lin S, Li X, Peng Z.   +15 more
europepmc   +1 more source

Cancer Heterogeneity and Cancer Cell Plasticity: Molecular Mechanisms and Precision Therapy

MedComm, Volume 7, Issue 7, July 2026.
Tumor progression is driven by heterogeneity occurring across multiple biological scales. At the molecular level, tumor cells exhibit alterations across distinct omics layers, including genomic mutations, epigenomic reprogramming, transcriptional changes, and proteomic remodeling, collectively shaping tumor cell phenotypes and functional states.
Hanwen Hu, Zhixing Hao, Lili Li, Huiying Liu, Chenghui Yang, Zhen Wang   +5 more
wiley   +1 more source